Lupin has launched Azilsartan Medoxomil tablets in the US after securing FDA approval, becoming the exclusive first-to-file generic applicant and gaining 180 days of...
India's pharmaceutical industry is entering a new phase where innovation, rather than traditional generic drugs alone, could become the biggest driver of growth over...
Lupin Ltd has entered into a strategic collaboration with Spanish pharmaceutical company LABORATORIOS ERN S.A. for the launch of Luforbec (beclometasone/formoterol) in Spain, marking...
Pharmaceutical firm Lupin Ltd on Thursday (June 4) said it has received approval from the United States Food and Drug Administration (USFDA) for Ranluspec...